Growth factor treatment of fractures.
Einhorn
T A
TA
Department of Orthopaedics, Mount Sinai School of Medicine, New York, New York, USA.
Trippel
S B
SB
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use; D050723:Fractures, Bone / Q000628:therapy*; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use; D016212:Transforming Growth Factor beta / Q000627:therapeutic use
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D016212:Transforming Growth Factor beta; D007334:Insulin-Like Growth Factor I